Article info

Download PDFPDF
Clopidogrel reduces platelet–leucocyte aggregation, monocyte activation and RANTES secretion in type 2 diabetes mellitus
  1. Correspondence to:
    Dr Scott Harding
    Department of Cardiology, Wellington Hospital, Private Bag 7902, Wellington, New Zealand; scott.harding{at}ccdhb.org.nz
View Full Text

Citation

Harding SA, Sarma J, Din JN, et al
Clopidogrel reduces platelet–leucocyte aggregation, monocyte activation and RANTES secretion in type 2 diabetes mellitus

Publication history

  • Accepted March 3, 2006
  • First published August 14, 2006.
Online issue publication 
March 15, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.